Fibrodysplasia Ossificans Progressiva

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: The Fibrodysplasia Ossificans Progressiva (FOP) Registry

  This clinical trial registry entry describes the ongoing recruitment for the Fibrodysplasia Ossificans Progressiva (FOP) Registry, sponsored…

• CLINICAL_TRIALS research · 2026-04-01
  Clinical Trial Update: A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

  Ipsen is conducting a long-term safety and effectiveness study of palovarotene in people with fibrodysplasia ossificans progressiva; the tri…

• CLINICAL_TRIALS research · 2026-03-03
  Clinical Trial Update: IL1 Inhibition in FOP

  A clinical trial is evaluating an IL-1–inhibiting therapy for fibrodysplasia ossificans progressiva and is currently recruiting.

• CLINICAL_TRIALS research · 2025-12-24
  Clinical Trial Update: An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

  This update describes Regeneron's expanded access program for garetosmab in adults with Fibrodysplasia Ossificans Progressiva (FOP), which i…

• CLINICAL_TRIALS research · 2025-12-05
  Clinical Trial Update: To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva [Phase 2]

  This clinical trial update indicates that INCB000928 is being studied in Phase 2 for fibrodysplasia ossificans progressiva and is currently …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-10-14
  Clinical Trial Update: A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) [Phase 2, Phase 3]

  An update on a Phase 2/3 study of andecaliximab for Fibrodysplasia Ossificans Progressiva, sponsored by Ashibio Inc, currently active but no…